Yangjingyi Ruan

SOCIAL MEDIA LEADER

Biographical sketch:

Yangjingyi is a dedicated oncology researcher who is pursuing her PhD in Pharmacology at Weill Cornell Medicine/Memorial Sloan Kettering Cancer Center. Her research focuses on developing a novel small molecule inhibitor of the Autophagy Lysosomal Pathway in pancreatic adenocarcinoma. She has keen interests in biomedical-related entrepreneurship, equity research, venture capital, and other career options that center on bringing life sciences into a business setting.